1. Role: Director. Scope: Department. Date: 2019.
Grant H. Skrepnek, Ph.D., R.Ph.
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47105
Fax (4050 271-6430
Office CPB 214
Email grant-skrepnek@ouhsc.edu
Summary
I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Research
Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Publications & Presentations
- 21. Dickson M C, Nguyen M M, Skrepnek G H. Medicaid Value-Based Contract (VBC) in the prevention of migraine [Legislative Report]. Oklahoma Health Care Authority. 2021
22. Schwier N C, Cannedy J J, Skrepnek G H. Management of Acute Idiopathic (Viral) Pericarditis in the Emergency Department: A Review for the Nursing Professional. Advanced emergency nursing journal. 2020; 42 : 17-29
23. Schwier N C, Cannedy J J, Skrepnek G H. Management of Acute Idiopathic (Viral) Pericarditis in the Emergency Department: A Review for the Nursing Professional. Advanced emergency nursing journal. 2020; 42 : 17-29
24. Gentry C A, Nguyen P K, Thind S, Kurdgelashvili G, Skrepnek G H, Williams R J. Fidaxomicin versus Oral Vancomycin for Severe Clostridium difficile Infection. Clinical Microbiology and Infection . 2019; 25 : 987-993
25. Pham T, Rathbun C, Keast S, Nesser N, Farmer K, Skrepnek G H. National estimates of case-mix, mortality, and economic outcomes amoung inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the U.S. Journal Evaluation Clinical Practice. 2019; 25 : 806-821
Grants
- 11. Improving the Health of Americans through Prevention and Management of Diabetes, Heart Disease, and Stroke. Non-federal. Start Date: 2019. End Date: 2020.
12. Allergan (PI: Keast). Federal Non-NIH. Start Date: 2018. End Date: 2019.
13. Otsuka (Skrepnek/Keast PI). Non-federal. Start Date: 2018. End Date: 2019.
14. Research Fellowship. PhRMA. Start Date: 2017. End Date: 2018.
15. Development of a Predictive Model for METAVIR Fibrosis Scores for Patients Chronically Infected with Hepatitis C Virus. Misc Non-Federal. Start Date: 2017.
Awards and Honors
- 1. Academy of Managed Care Pharmacy Nexus 2022, National Harbor, MD, Oct. 11-14, 2022. Top Conference Poster (Student, Matthew C. Dickson). Date: 2022.
2. Academy of Managed Care Pharmacy. Bronze Recognition. Date: 2015.
3. International Symposium of the Diabetic Foot. Top Conference Podium. Date: 2015.
Education
no results
Administrative Assignments
2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.